Compare · BXRX vs SHC
BXRX vs SHC
Side-by-side comparison of Baudax Bio Inc. (BXRX) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BXRX and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $4.43B, about 301.5x BXRX ($14.7M).
- SHC has hit the wire 23 times in the past 4 weeks while BXRX has been quiet.
- SHC has more recent analyst coverage (25 ratings vs 0 for BXRX).
- Company
- Baudax Bio Inc.
- Sotera Health Company
- Price
- $0.18+5.03%
- $15.55-0.58%
- Market cap
- $14.7M
- $4.43B
- 1M return
- -
- -0.13%
- 1Y return
- -
- +27.51%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 23
- Recent ratings
- 0
- 25
Baudax Bio Inc.
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest BXRX
- SEC Form 8-K filed by Baudax Bio Inc.
- SEC Form 25-NSE filed by Baudax Bio Inc.
- SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)
- SEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)
- Baudax Bio Inc. filed SEC Form 8-K: Other Events
- CORRECTION: BioCryst Pharmaceuticals Ticker is "BCRX
- BioCryst Pharmaceuticals Updated Its Agreement With Torii Pharmaceutica For ORLADEYO In Japan; BioCryst Japan K.K. Responsible For All Commercial Promotion Activities And Torii Will Be Responsible For Hereditary Angioedema Disease Awareness Activities
- SEC Form 424B3 filed by Baudax Bio Inc.
- SEC Form 10-Q filed by Baudax Bio Inc.
- SEC Form NT 10-Q filed by Baudax Bio Inc.
Latest SHC
- SEC Form SD filed by Sotera Health Company
- Director Klee Ann R. was granted 14,970 shares, increasing direct ownership by 12% to 140,926 units (SEC Form 4)
- Chief Executive Officer Shader Alton was granted 579,573 shares (SEC Form 4)
- SEC Form 3 filed by new insider Shader Alton
- Director Kyle Richard G was granted 14,970 shares (SEC Form 4)
- Director Krause Kenneth D. was granted 14,970 shares (SEC Form 4)
- Director Cunningham Sean Laurence was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)
- Director Flynn Karen was granted 14,970 shares, increasing direct ownership by 38% to 54,191 units (SEC Form 4)
- Director Neary James was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)
- Director Petrella Vincent K was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)